The systemic inflammation response index predicts the survival of patients with clinical T1‐2N0 oral squamous cell carcinoma

The systemic inflammation response index predicts the survival of patients with clinical T1‐2N0 oral squamous cell carcinoma

Objective The systemic inflammation response index (SIRI) is an independent prognostic factor for many malignant tumors. However, the value of this factor in patients with clinical T1‐2N0 (cT1‐2N0) oral squamous cell carcinoma (OSCC) is still unclear. Methods We calculated SIRI of 235 cT1‐2N0 OSCC p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral diseases 2022-04, Vol.28 (3), p.600-610
Hauptverfasser: Song, Fan, Cai, Hongshi, Liao, Yan, Huang, Shuojin, Jiang, Yaoqi, Liang, Jianfeng, Xie, Nan, Hou, Jinsong
Format: Artikel
Sprache:eng
Schlagworte:
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Humans
Inflammation
Inflammation - pathology
Leukocytes (neutrophilic)
Lymphocytes
Monocytes
monocyte‐to‐lymphocyte ratio
Mouth Neoplasms
neutrophil‐to‐lymphocyte ratio
Oral cancer
Oral carcinoma
Oral squamous cell carcinoma
Patients
Prognosis
Retrospective Studies
Squamous cell carcinoma
Squamous Cell Carcinoma of Head and Neck
survival
Survival analysis
systemic inflammation response index
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective The systemic inflammation response index (SIRI) is an independent prognostic factor for many malignant tumors. However, the value of this factor in patients with clinical T1‐2N0 (cT1‐2N0) oral squamous cell carcinoma (OSCC) is still unclear. Methods We calculated SIRI of 235 cT1‐2N0 OSCC patients from 2013 to 2017. Multivariate cox regression analysis was applied to verify the prognostic significance of SIRI. Kaplan–Meier curves were plotted to analyze the overall survival (OS) and disease‐specific survival (DSS) for cT1‐2N0 OSCC patients. Results According to the optimal cutoff point of SIRI, we divided cT1‐2N0 OSCC patients into high SIRI group (SIRI ≥ 1.3) and low SIRI group (SIRI 
ISSN:1354-523X
1601-0825
DOI:10.1111/odi.13782